NCT03190889

Brief Summary

The overall goal of this project is to reduce risk of second anterior cruciate ligament (ACL) injury in vulnerable populations (active athletes between 14 = 24 years old) through the identification of relative injury risk groups based on subject-specific movement patterns prior to second injury, as well as through the determination of effect for differential rehabilitation protocols following initial ACL reconstruction and prior to return to sport. As nearly one-third of athletes who have a primary ACL injury and return to sport will experience a secondary injury, results from the proposed work will allow us to prospectively identify high risk patients who are the most appropriate recipients of enhanced treatment, including targeted training, which may reduce the risk of second ACL injury. Secondary ACL injury has the potential to end athletic careers, promote the development of osteoarthritis, and have debilitating effects on quality of life. Hence, the information gathered in this investigation will offer ACL injured athletes the optimal potential to reduce or potentially prevent these negative health effects before they are initiated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
1.1 years until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
10 months until next milestone

Results Posted

Study results publicly available

April 11, 2025

Completed
Last Updated

March 11, 2026

Status Verified

February 1, 2026

Enrollment Period

5.9 years

First QC Date

May 15, 2017

Results QC Date

October 29, 2024

Last Update Submit

February 18, 2026

Conditions

Keywords

ACL ReconstructionRehabilitationSports InjuryNeuromuscular InterventionKnee Injury

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Second ACL Injury

    Subjects recruited for this investigation will be recovering from primary ACL injury. Participants will be monitored for injury history from time of enrollment in study. Report of any additional ACL injury whether contralateral leg or involved leg will be counted as a second ACL injury.

    12-48 months

Secondary Outcomes (2)

  • Frontal Plane Knee Kinetics

    Change after 6 weeks of interventional protocol

  • Frontal Plane Knee Kinematics

    Change after 6 weeks of interventional protocol

Study Arms (3)

Standard of Care Group

NO INTERVENTION

Patients in the STAN group will participate in twelve sessions of supervised physical therapy over a six week period. Patients will participate in agility and plyometric drills, and continue strength exercises from the previous treatment phase. The clinic program will be performed in conjunction with a home running program. Patients in this group will not receive feedback from the therapist regarding movement quality during activities.

Control Group

OTHER

HOME Program is distinguished by patients participating in a home only intervention that consists of running and strengthening exercises performed twice a week for six weeks. No plyometric or agility drills are performed in this study arm. This represents the minimal intervention to prepare for a return to sports. No neuromuscular training or movement training beyond the sagittal plane will be performed.

Other: HOME

Intervention Group with Neuromuscular Training

EXPERIMENTAL

Patients who are enrolled in the TNMT group will participate in 12 sessions of supervised outpatient physical therapy over a six week period. The TNMT protocol is distinguished by performance of exercises designed to enhance core and hip strength, performance of neuromuscular training exercise that are designed to correct movement flaws associated with second ACL injury25, providing verbal and visual feedback and performance of single leg drills on both legs.

Other: TNMT

Interventions

HOMEOTHER

At home rehabilitation following ACL reconstructive surgery as described in the HOME arm.

Control Group
TNMTOTHER

Standard of care, clinical rehabilitation following ACL reconstructive surgery with the addition of specified targeted neuromuscular training as described in the TNMT arm.

Intervention Group with Neuromuscular Training

Eligibility Criteria

Age13 Years - 30 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsPlanned distribution of subjects: US census reports for 2014 indicate the female sex comprises approximately 50% of the population in Olmsted (Rochester, MN) county. We therefore anticipate women will comprise approximately half of the study population.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age, 13 ≥ 30 years
  • Acute (\< 6 months), first-time, isolated ACL injury
  • No history of previous knee surgery to either extremity
  • No low back or lower extremity injury in the year prior to ACL injury necessitating medical care
  • Pre-injury participation in cutting, jumping or pivoting sports for ≥ 50 hours/year
  • Mechanism of injury did not involve a direct blow to the knee.
  • Patients who sustain a medial collateral ligament (MCL) injury are eligible for study participation if medial knee instability is resolved prior to surgery
  • Patients with simple meniscus tears (i.e., 2 cm vertical longitudinal tear) that do not necessitate alterations in rehabilitation will be eligible for study participation

You may not qualify if:

  • History of previous knee surgery to either extremity
  • Low back or lower extremity injury in the year prior to ACL injury necessitating medical care
  • Second or greater ACL injury
  • Greater than 6 months since occurrence of ACL injury
  • Lack of participation in cutting, jumping, or pivoting sport
  • Mechanisms of injury involved a direct blow of force to the knee
  • Patients with MCL injury that exhibits unresolved medial knee instability
  • Patients with complex, repairable meniscus tears (i.e., radial or root repair) and patients with full thickness articular cartilage lesions will not be eligible for participation secondary to significant alterations to postoperative rehabilitation protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Emory University

Flowery Branch, Georgia, 30542, United States

Location

Mayo Clinic Square

Minneapolis, Minnesota, 55403, United States

Location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

The Ohio State University Wexner Medical Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Athletic InjuriesKnee Injuries

Condition Hierarchy (Ancestors)

Wounds and InjuriesLeg Injuries

Results Point of Contact

Title
Nathaniel A. Bates
Organization
The Ohio State University Wexner Medical Center

Study Officials

  • Aaron J Krych, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Subjects are masked from group assignment. Group assignment is randomized.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Overall Strategy. This is a prospective, randomized, repeated measures single- blind clinical trial. The purposes of this study are to 1) stratify patient risk for second ACL injury, and 2) determine the effects of differential treatment intervention, including targeted neuromuscular training (TNMT), home program only (HOME) and standard clinical (STAN) training, on clinical, biomechanical, and neuromuscular performance measures associated with an increased ACL injury risk. After the initial ACL injury and study enrollment, all patients will participate in standardized pre-operative rehabilitation. They will then undergo surgery by a fellowship-trained sports medicine surgeon at Mayo Clinic, Rochester, MN. Data for Aim 1 will be obtained from biomechanical, neuromuscular and clinical testing performed during Pre-Testing. Data for Aim 2 and the Exploratory Aim will be obtained from biomechanical and clinical test results obtained from Pre- and Post-Testing time points.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 15, 2017

First Posted

June 19, 2017

Study Start

August 1, 2018

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

March 11, 2026

Results First Posted

April 11, 2025

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations